Rapamycin-filgrastim combination therapy ameliorates portal hypertension-induced splenomegaly: Role of β actin and S100A9 proteins modulation

OBJECTIVE(S): Thioacetamide (TAA) was administered to induce an animal model of liver disease with secondary splenomegaly to assess the mechanisms underlying the effects of rapamycin and filgrastim when taken separately or in combination on the biochemical and histopathological aspects of the liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelrahman, Shaimaa A., Abdelfatah, Mohammed M., Keshta, Akaber T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320204/
https://www.ncbi.nlm.nih.gov/pubmed/35949314
http://dx.doi.org/10.22038/IJBMS.2022.64034.14101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320204/
https://www.ncbi.nlm.nih.gov/pubmed/35949314
http://dx.doi.org/10.22038/IJBMS.2022.64034.14101

Ejemplares similares